A 13-gene panel may help predict response to chemotherapy in triple-negative breast cancer

Researchers at The University of Texas MD Anderson Cancer Center have characterized cancer cell-specific features in the ...
ascopubs.org

Repurposing hemostatic drug desmopressin in AVPR2-expressing triple-negative breast cancer: Target expression analysis and preclinical antineoplastic effects on tumor growth ...

Effect of DeltaRex-G ± DeltaRex-G Plus (an FDA-approved drug) on advanced chemoresistant pancreatic cancer, sarcoma, and breast cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
Cure Today

Gene Expression Testing and Targeted Therapies in Breast Cancer Care

Gene expression testing, such as Oncotype DX, aids in chemotherapy decisions for hormone receptor-positive breast cancer, though challenges exist for premenopausal patients with scores under 25.
ascopubs.org

Steroid receptor expression and overall survival in breast cancer patients with ER+ bone metastasis: A retrospective review.

Comparing clinical benefit of trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in a large cohort of HER2-negative metastatic breast cancer (MBC). This is an ASCO Meeting Abstract from the ...